FCGRs Polymorphisms and Response to Trastuzumab in Patients With HER2-Positive Breast Cancer: Far From Predictive Value?

BACKGROUND: The aim of the study was to validate the association between the Arg166His polymorphisms of the Fc immunoglobulin receptor 2A (FCGR2A) and the Val212Phe of FCGR3A and pathological clinical response (pCR) to trastuzumab in HER2-positive breast cancer patients. METHODS: Polymorphisms were...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:World J Oncol
Main Authors: Botticelli, Andrea, Mazzuca, Federica, Borro, Marina, Mazzotti, Eva, La Torre, Marco, Bonifacino, Adriana, Ciabatta, Francesca Romana, Gentile, Giovanna, Maddalena, Chiara, Simmaco, Maurizio, Marchetti, Paolo
Formato: Artigo
Idioma:Inglês
Publicado em: Elmer Press 2015
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5624668/
https://ncbi.nlm.nih.gov/pubmed/28983344
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/wjon934w
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados